Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_assertion type Assertion NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_head.
- NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_assertion wasGeneratedBy ECO_0000203 NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_provenance.
- NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_assertion wasDerivedFrom befree-20150227 NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_provenance.
- NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_assertion SIO_000772 17713473 NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_provenance.
- NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_assertion evidence source_evidence_literature NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_provenance.
- NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_assertion description "[After adjusting for performance status, previous platinum-containing chemotherapy and occurrence of skin rash or diarrhea during the first treatment cycle in patients with performance status 0 or 1 (N=139), the absence of EGFR*1 was associated with significantly better survival (hazard ratio: 0.54; 95% confidence interval: 0.32-0.91; P=0.015).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368614.RAcCLce3HIfEvz3lo5CwS5Ucd5CuW3wuSJfZaAjhPEuP8130_provenance.